The purpose of this study is to evaluate if ZTI-01 (fosfomycin for injection), an
investigational drug being developed to treat people with complicated urinary tract and
kidney infections, has any effect on the electrical activity of the heart.
Phase:
Phase 1
Details
Lead Sponsor:
Nabriva Therapeutics AG Zavante Therapeutics
Treatments:
Fluoroquinolones Fosfomycin Moxifloxacin Norgestimate, ethinyl estradiol drug combination